• 제목/요약/키워드: morbidity of respiratory diseases

Search Result 133, Processing Time 0.028 seconds

A Study on the morbid status of a rural area and comparison of its study methodology (일부(一部) 농촌주민(農村住民)의 상병현황조사(傷病現況調査)와 조사기법(調査技法)의 비교연구(比較硏究))

  • Lee, Eun-Il;Min, Jae-Gee;Song, Dong-Bin
    • Journal of agricultural medicine and community health
    • /
    • v.9 no.1
    • /
    • pp.39-45
    • /
    • 1984
  • This research was done to gain the health information in one of the target areas(rural area) of the Korea University Community Health Project, and to improve and standardize the methodology of the health interview survey. There were two types of questions;one was the simple open-ended question and the other was check list in the interview survey for a total of 1,406 inhabitants. And so the result obtained from the above survey was analysed. The results as follows; 1) The morbidity rate in general was 11.2% by simple open-ended question and 32.5% by check list during recent 20 days in interview method. 2) Women had higher morbidity rate in both kinds of method. 3) The most prevalent diseases in the interview method using check list were the ones of the musculo-skeletal system and connective tissue (22.5%), and diseases of the respiratory system (19.8%) and digestive system (13.7%) were in order of frequency. 4) By the position in the family, housewives had highest morbidity rate in the interview method unrespectedly, and the reason seemed that the respondents were houseweives themselves and the morbidity rate was the one by spell not by person. But morbidity rate by the socio-economic status had no significant difference in both methods. 5) The agreement rate on simple open-ended question and check list was 72.5%, but if limiting respondents themselves only, the rate was falled to 54%. 6) The morbidities were diverse in the review of the results of previous morbidity surveies, but the morbidity rate was higher and less variable in case of using check list and getting the replies individually than using simple open-ended question and proxy respondents.

  • PDF

Epidemiological Investigation of Diseases in Korean Native Suckling Calves (한우 신생송아지의 질병발생에 관한 조사연구)

  • Kwon, Oh-Deog;Choi, Kyoung-Seong;Lee, Seung-Ok;Jang, Hwan;Lee, Joo-Mook
    • Journal of Veterinary Clinics
    • /
    • v.17 no.1
    • /
    • pp.93-101
    • /
    • 2000
  • This study was carried out to investigate the epidemiological prevalence of diseases from birth to weaning in 268 Koeran native calves which was delivered from three stock farm in Chonbuk area. We examined body weight gain, incidence rate of diseases and mortality rate in relation to age, season, environmental temperature and rearing management conditions for one year. The results of this experiment were as follows: Birth weight and body weight gain of Korean native calves born of primiparae were lower than those of multiparae. Body weight gain of diseased calves was lower than normal calves. Of 268 delivered calves, 242 calves(90.3%) were affected with gastronistestinal and/or respiratory diseases. The prevalence of the diseases were gastronitestinal disease(54.1%), gastronitestinal and respiratory disease(21.6%), and respiratory disease(14.5%). Of 242 diseased calves, 33 calves(13.6%) were occurred gastronitestinal disease and respiratory disease at different time respectively. Of 268 delivered calves, 126 calves were died(47%). The prevalence of the death were gastronitestinal disease(31.4%), gastronitestinal and respiratory disease(14.5%), and respiratory disease(1.1%). 81% of the diseases and 76.2% of the death were occurred in winter and a change of season(December to May). 59.1% of the diseases and 52.4% of the death were occurred at atmospheric temperatures below 1$0^{\circ}C$. 91.7% of the diseased calves and 96.8% of the dead calves were born of primiparae. 77.2% of the gastronitestinal disease were occurred within 2 weeks old, and the incidence was decreased with increasing age. Whereas the incidence of respiratory disease was incidence with ageing, and 69.2% of the respiratory disease were occurred between 2 weeks and 5 weeks old. And 62% of the gastronitestinal and respiratory disease wre occurred between 1 week and 3 weeks old. 65.1% of the dead calves were died within 2 weeks old. The morbidity and population mortality rate in each farm stock were 56.5%-104.9%, and 14.5%-64.2%, respectively.

  • PDF

Adverse Effects of Air Pollution on Pulmonary Diseases

  • Ko, Ui Won;Kyung, Sun Young
    • Tuberculosis and Respiratory Diseases
    • /
    • v.85 no.4
    • /
    • pp.313-319
    • /
    • 2022
  • Environmental exposure to air pollution is known to have adverse effects on various organs. Air pollution has greater effects on the pulmonary system as the lungs are directly exposed to contaminants in the air. Here, we review the associations of air pollution with the development, morbidity, and mortality of pulmonary diseases. Short-and long-term exposure to air pollution have been shown to increase mortality risk even at concentrations below the current national guidelines. Ambient air pollution has been shown to be associated with lung cancer. Particularly long-term exposure to particulate matter with a diameter <2.5 ㎛ (PM2.5) has been reported to be associated with lung cancer even at low concentrations. In addition, exposure to air pollution has been shown to increase the incidence risk of chronic obstructive pulmonary disease (COPD) and has been correlated with exacerbation and mortality of COPD. Air pollution has also been linked to exacerbation, mortality, and development of asthma. Exposure to nitrogen dioxide (NO2) has been demonstrated to be related to increased mortality in patients with idiopathic pulmonary fibrosis. Additionally, air pollution increases the incidence of infectious diseases, such as pneumonia, bronchitis, and tuberculosis. Furthermore, emerging evidence supports a link between air pollution and coronavirus disease 2019 transmission, susceptibility, severity and mortality. In conclusion, the stringency of air quality guidelines should be increased and further therapeutic trials are required in patients at high risk of adverse health effects of air pollution.

A Case of Antiphospholipid Syndrome Refractory to Secondary Anticoagulating Prophylaxis after Deep Vein Thrombosis-Pulmonary Embolism

  • Gu, Kang Mo;Shin, Jong Wook;Park, In Won
    • Tuberculosis and Respiratory Diseases
    • /
    • v.77 no.6
    • /
    • pp.274-278
    • /
    • 2014
  • Antiphospholipid syndrome (APS) is an acquired systemic autoimmune disorder characterized by a combination of clinical criteria, including vascular thrombosis or pregnancy morbidity and elevated antiphospholipid antibody titers. It is one of the causes of deep vein thrombosis and pulmonary embolism that can be critical due to the mortality risk. Overall recurrence of thromboembolism is very low with adequate anticoagulation prophylaxis. The most effective treatment to prevent recurrent thrombosis is long-term anticoagulation. We report on a 17-year-old male with APS, who manifested blue toe syndrome, deep vein thrombosis, pulmonary thromboembolism, and cerebral infarction despite adequate long-term anticoagulation therapy.

The Latest Achievements in Study of Tuberculosis (결핵 연구의 최근 성과들)

  • Yim, Jae-Joon
    • Tuberculosis and Respiratory Diseases
    • /
    • v.71 no.6
    • /
    • pp.395-399
    • /
    • 2011
  • Tuberculosis is one of the leading causes of mortality and morbidity worldwide. In 2010, there were 8.8 million (range, 8.5~9.2 million) incident cases of TB, 1.1 million deaths from TB among HIV-negative people and an additional 0.35 million deaths from HIV-associated TB. Due to such health-related importance, tuberculosis is one of areas being actively researched. Many numbers of tuberculosis-related papers are being presented each year, and in this review, it summarizes contents of a few papers that had been selected among the papers presented from 2009 to early 2011.

Malignant Pleural Effusion: Medical Approaches for Diagnosis and Management

  • Nam, Hae-Seong
    • Tuberculosis and Respiratory Diseases
    • /
    • v.76 no.5
    • /
    • pp.211-217
    • /
    • 2014
  • Malignant pleural effusions (MPEs) are the second leading cause of exudative pleural effusions after parapneumonic effusions. In the vast majority of cases, a MPE signifies incurable disease associated with high morbidity and mortality. Considerable advances have been made for the diagnosis of MPEs, through the development of improved methods in the specialized cytological and imaging studies. The cytological or histological confirmation of malignant cells is currently important in establishing a diagnosis. Furthermore, despite major advancements in cancer treatment for the past two decades, management of MPE remains palliative. This article presents a comprehensive review of the medical approaches for diagnosis and management of MPE.

Pneumonia in Immunocompromised Patients (면역저하 환자에서의 폐렴)

  • Yoon, Hyoung-Kyu
    • Tuberculosis and Respiratory Diseases
    • /
    • v.70 no.5
    • /
    • pp.371-383
    • /
    • 2011
  • The number of immunocompromised patients has increased over the past decades due to HIV infection, solid and stem cell transplantation, intensified chemotherapy and treatment of autoimmune disease. Pneumonia is a major cause of both morbidity and mortality in immunocompromised patients. Clinical management of pneumonia is difficult, since differential diagnosis in this setting is broad and includes both infectious and noninfectious processes. Because the development of pneumonia in immunocompromised patients is frequently life threatening, early therapeutic and diagnostic intervention is essential to obtain better outcomes.

Lung Regeneration Therapy for Chronic Obstructive Pulmonary Disease

  • Oh, Dong Kyu;Kim, You-Sun;Oh, Yeon-Mok
    • Tuberculosis and Respiratory Diseases
    • /
    • v.80 no.1
    • /
    • pp.1-10
    • /
    • 2017
  • Chronic obstructive pulmonary disease (COPD) is a critical condition with high morbidity and mortality. Although several medications are available, there are no definite treatments. However, recent advances in the understanding of stem and progenitor cells in the lung, and molecular changes during re-alveolization after pneumonectomy, have made it possible to envisage the regeneration of damaged lungs. With this background, numerous studies of stem cells and various stimulatory molecules have been undertaken, to try and regenerate destroyed lungs in animal models of COPD. Both the cell and drug therapies show promising results. However, in contrast to the successes in laboratories, no clinical trials have exhibited satisfactory efficacy, although they were generally safe and tolerable. In this article, we review the previous experimental and clinical trials, and summarize the recent advances in lung regeneration therapy for COPD. Furthermore, we discuss the current limitations and future perspectives of this emerging field.

Interstitial Lung Disease and Diffuse Alveolar Hemorrhage, the Two Key Pulmonary Manifestations in Microscopic Polyangiitis

  • Kim, Min Jung;Shin, Kichul
    • Tuberculosis and Respiratory Diseases
    • /
    • v.84 no.4
    • /
    • pp.255-262
    • /
    • 2021
  • Microscopic polyangiitis (MPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated necrotizing vasculitis, which mainly affects small vessels in various organs, especially the lungs. The two key pulmonary manifestations, interstitial lung disease (ILD) and diffuse alveolar hemorrhage (DAH), increase the morbidity and death rate of patients with MPA. ILD is more common in MPA than in other ANCA-associated vasculitis subsets and is primarily associated with myeloperoxidase-ANCA. Unlike alveolar hemorrhage due to pulmonary capillaritis, ILD can initially manifest as isolated pulmonary fibrosis. Of note, its most frequent radiographic pattern is the usual interstitial pneumonia pattern, similar to the characteristic pattern seen in idiopathic pulmonary fibrosis. In this review we present the pathogenesis, clinical manifestations, and radiographic and histopathologic features of ILD and DAH in MPA. We also briefly summarize the outcome and therapeutic options for the two conditions.

Healthcare-Associated Pneumonia (의료기관관련 폐렴)

  • Lee, Heung-Bum;Han, Hyo-Jin
    • Tuberculosis and Respiratory Diseases
    • /
    • v.70 no.2
    • /
    • pp.105-112
    • /
    • 2011
  • Pneumonia is frequently encountered in the clinical fields, both as a cause for admission and as a complication of the underlying disorder or as the course of treatment. Pneumonia is the second most common hospital-acquired infection and is associated with the highest morbidity and mortality rates among hospital-acquired infections. The guidelines for the management of hospital-acquired pneumonia by the American Thoracic Society include identifying individuals who have recently received antibiotics therapy or have been in medical facilities; these individuals are at higher risk for infection with multiple drug resistant organisms. Individuals, who have acquired pneumonia according to this clinical scenario, have what is known as healthcare-associated pneumonia (HCAP). Patients with HCAP should be considered to have potentially drug-resistant pathogens and should receive broad spectrum empiric antibiotic therapy directed at the potentially resistant organisms. In this paper, the diagnosis, risk factors, and treatment of HCAP are discussed.